Search

Your search keyword '"Marrouche, Nassir"' showing total 221 results

Search Constraints

Start Over You searched for: Author "Marrouche, Nassir" Remove constraint Author: "Marrouche, Nassir" Publisher elsevier bv Remove constraint Publisher: elsevier bv
221 results on '"Marrouche, Nassir"'

Search Results

1. Prognosis of patients in end-stage heart failure with atrial fibrillation treated with ablation - Insights from Castle HTX

3. Smartphone Atrial Fibrillation Burden During the Blanking Period Predicts Catheter Ablation Outcomes

4. Delayed Enhancement Cardiac Magnetic Resonance Imaging Detects Disease Progression in Patients with Mitral Valve Disease and Atrial Fibrillation.

6. Does early detection of atrial fibrillation reduce the risk of thromboembolic events? Rationale and design of the Heartline study

7. PO-03-120 ABLATION SCAR FORMATION IS SUPERIOR WITH THE KODEX-EPD MAPPING SYSTEM IN PERSISTENT ATRIAL FIBRILLATION PATIENTS

8. PO-01-099 EARLY REMODELING OF THE LEFT ATRIUM FOLLOWING CATHETER ABLATION OF PERSISTENT ATRIAL FIBRILLATION: THE IMPACT OF SUBSTRATE MODIFICATION IN DECAAF II

9. PO-01-199 ABLATION PARAMETERS AS PREDICTORS OF ATRIAL ARRHYTHMIA RECURRENCE AFTER PULMONARY VEIN ISOLATION ALONE IN PERSISTENT AF: A DECAAF II SUBSTUDY

10. CE-452780-1 LEFT ATRIAL VOLUME IS THE STRONGEST PREDICTOR OF ATRIAL ARRHYTHMIA RECURRENCE AFTER PULMONARY VEIN ISOLATION ALONE IN PERSISTENT AF: A DECAAF II SUBSTUDY

11. PO-02-094 ALL PULMONARY VEIN ISOLATION STRATEGIES ARE EQUALLY EFFECTIVE IN REDUCING THE RECURRENCE OF ATRIAL ARRHYTHMIAS

12. PO-02-168 ONE-YEAR OUTCOMES OF PULMONARY VEIN ISOLATION WITH A NOVEL CRYOBALLOON IN 325 PATIENTS: PRIMARY RESULTS OF THE FROZEN AF TRIAL

13. PO-03-093 EFFECT OF CATHETER ABLATION FOR ATRIAL FIBRILLATION ON LEFT ATRIAL FUNCTION AND LEFT VENTRICULAR DIASTOLIC FILLING

14. PO-01-169 CLINICAL APPLICATION OF A NOVEL 31MM CRYOBALLOON FOR PULMONARY VEIN ISOLATION FOR PAROXYSMAL ATRIAL FIBRILLATION: PROCEDURAL DATA FROM THE FIT ARM OF FROZEN AF

17. PO-03-202 WOMEN TRAINEES IN ELECTROPHYSIOLOGY AND THE EFFECT OF ROLE MODELS

19. CE-452778-4 SKIPPING ABLATION LESIONS DOES NOT AFFECT ATRIAL ARRHYTHMIA RECURRENCE AFTER PULMONARY VEIN ISOLATION IN PERSISTENT AF: A DECAAF II SUBSTUDY

20. PO-02-219 MODIFIABLE RISK FACTORS PREDICT THE RECURRENCE OF ARRHYTHMIA AFTER PERSISTENT AF ABLATION: ANALYSIS OF THE DECAAF II STUDY

22. EARLIEST RECURRENCE DURING THE BLANKING PERIOD PREDICTS ABLATION OUTCOMES: INSIGHTS FROM DECAAF II

23. ATRIAL FIBRILLATION BURDEN AFTER CATHETER ABLATION FOR PERSISTENT ATRIAL FIBRILLATION IS THE SAME REGARDLESS OF HEART FAILURE STATUS

24. LEFT ATRIAL VOLUME AND AGE ARE THE STRONGEST PREDICTORS OF ATRIAL FIBRILLATION BURDEN AFTER PULMONARY VEIN ISOLATION FOR PERSISTENT ATRIAL FIBRILLATION- FINDINGS FROM DECAAF II RANDOMIZED CONTROLLED TRIAL

25. DIRECT ORAL ANTICOAGULANTS ARE AS EFFICACIOUS AS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH CANCER

26. EFFECT OF FIBROSIS REGIONALITY ON ATRIAL FIBRILLATION RECURRENCE

27. REGIONAL CHARACTERISTICS OF THE LEFT ATRIAL WALL IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION

28. PATIENTS WHO FAIL ATRIAL FIBRILLATION ABLATION BY TRADITIONAL CRITERIA STILL BENEFIT FROM IMPROVEMENTS IN QUALITY OF LIFE AND CARDIAC REMODELING

29. BASELINE NATRIURETIC PEPTIDES AS A PREDICTOR OF ATRIAL FIBRILLATION RECURRENCE AFTER CONVENTIONAL PULMONARY VEIN ISOLATION IN A NON-HEART FAILURE POPULATION: A SUBANALYSIS FROM DECAAF II

30. PREDICTORS OF IMPROVED QUALITY OF LIFE AFTER CATHETER ABLATION IN AF PATIENTS

32. LOW ATRIAL FIBROSIS PERCENTAGE IS ASSOCIATED WITH SIGNIFICANTLY REDUCED ATRIAL FIBRILLATION BURDEN FOLLOWING CATHETER ABLATION

33. DIRECT ORAL ANTICOAGULANTS DECREASE ALL-CAUSE MORTALITY COMPARED TO WARFARIN IN PATIENTS WITH OBESITY AND AF

35. Conduction system disease in cardiac amyloidosis

36. Atrial Fibrillation Burden Specifically Determines Human Ventricular Cellular Remodeling

37. The association of disparities in neighborhood median household income and mortality in patients admitted to the hospital with atrial fibrillation

49. BASELINE ATRIAL FIBROSIS IS ASSOCIATED WITH HIGHER ATRIAL FIBRILLATION BURDEN DURING THE BLANKING PERIOD

50. CARDIOVASCULAR COMORBIDITIES PREDISPOSE TO CARDIOVASCULAR COMPLICATIONS IN HOSPITALIZED PATIENTS WITH COVID-19 INFECTION

Catalog

Books, media, physical & digital resources